The guanine-quadruplex aptamer 93del inhibits HIV―1 replication ex vivo by interfering with viral entry, reverse transcription and integration

We have previously identified the guanine-rich oligonucleotide (ODN) 93del as a potent inhibitor in vitro of HIV-1 integrase. Moreover, low nanomolar concentrations of ODN 93del have been shown to inhibit HIV-1 replication in infected cells. To investigate the ex vivo mechanism of ODN 93del inhibiti...

Full description

Saved in:
Bibliographic Details
Published inAntiviral therapy Vol. 16; no. 3; pp. 383 - 394
Main Authors FAURE-PERRAUD, Aurélie, METIFIOT, Mathieu, REIGADAS, Sandrine, RECORDON-PINSON, Patricia, PARISSI, Vincent, VENTURA, Michel, ANDREOLA, Marie-Line
Format Journal Article
LanguageEnglish
Published London International Medical Press 01.01.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have previously identified the guanine-rich oligonucleotide (ODN) 93del as a potent inhibitor in vitro of HIV-1 integrase. Moreover, low nanomolar concentrations of ODN 93del have been shown to inhibit HIV-1 replication in infected cells. To investigate the ex vivo mechanism of ODN 93del inhibition, we analysed its antiviral effects on the early steps of HIV-1 replication such as viral entry, reverse transcription and integration using quantitative PCR. In addition to the effect on viral entry previously described for other guanine-quadruplex ODNs, transfection experiments showed that ODN 93del severely affects the proviral integration step independently of the effect on viral entry. Moreover, incubation of viral particles with ODN 93del revealed a potential microbicide activity of the aptamer. Our data point to an original multimodal inhibition of HIV-1 replication by ODN 93del, strongly suggesting that targets of guanine-quartet-forming ODNs involve entry as well as other intracellular early steps of HIV-1 replication.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1359-6535
2040-2058
DOI:10.3851/IMP1756